nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.332	0.521	CiPCiCtD
Clarithromycin—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.305	0.479	CiPCiCtD
Clarithromycin—CYP3A5—Beclomethasone—psoriasis	0.0248	0.0922	CbGbCtD
Clarithromycin—CYP1A2—Clobetasol propionate—psoriasis	0.0243	0.0906	CbGbCtD
Clarithromycin—SLC22A7—Methotrexate—psoriasis	0.0136	0.0506	CbGbCtD
Clarithromycin—CYP1A2—Methoxsalen—psoriasis	0.0128	0.0476	CbGbCtD
Clarithromycin—CYP3A7—Hydrocortisone—psoriasis	0.0105	0.0393	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0105	0.0393	CbGbCtD
Clarithromycin—CYP3A7—Cyclosporine—psoriasis	0.00996	0.0371	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00996	0.0371	CbGbCtD
Clarithromycin—CYP3A5—Mycophenolate mofetil—psoriasis	0.00986	0.0367	CbGbCtD
Clarithromycin—CYP2C19—Cholecalciferol—psoriasis	0.00917	0.0342	CbGbCtD
Clarithromycin—CYP3A4—Calcitriol—psoriasis	0.0086	0.0321	CbGbCtD
Clarithromycin—CYP3A5—Hydrocortisone—psoriasis	0.00791	0.0295	CbGbCtD
Clarithromycin—CYP3A5—Cyclosporine—psoriasis	0.00747	0.0278	CbGbCtD
Clarithromycin—CYP3A4—Methoxsalen—psoriasis	0.00669	0.0249	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00656	0.0244	CbGbCtD
Clarithromycin—CYP3A7—Dexamethasone—psoriasis	0.00656	0.0244	CbGbCtD
Clarithromycin—ABCB1—Mycophenolate mofetil—psoriasis	0.00641	0.0239	CbGbCtD
Clarithromycin—CYP2C19—Prednisone—psoriasis	0.00636	0.0237	CbGbCtD
Clarithromycin—CYP2C19—Cyclosporine—psoriasis	0.00602	0.0224	CbGbCtD
Clarithromycin—ABCB1—Betamethasone—psoriasis	0.0055	0.0205	CbGbCtD
Clarithromycin—ABCB1—Prednisolone—psoriasis	0.00543	0.0202	CbGbCtD
Clarithromycin—ABCB1—Hydrocortisone—psoriasis	0.00515	0.0192	CbGbCtD
Clarithromycin—ABCB1—Prednisone—psoriasis	0.00513	0.0191	CbGbCtD
Clarithromycin—CYP3A5—Dexamethasone—psoriasis	0.00492	0.0183	CbGbCtD
Clarithromycin—ABCB1—Cyclosporine—psoriasis	0.00486	0.0181	CbGbCtD
Clarithromycin—CYP3A4—Cholecalciferol—psoriasis	0.00443	0.0165	CbGbCtD
Clarithromycin—CYP2C19—Dexamethasone—psoriasis	0.00397	0.0148	CbGbCtD
Clarithromycin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00384	0.0143	CbGbCtD
Clarithromycin—CYP3A4—Triamcinolone—psoriasis	0.00384	0.0143	CbGbCtD
Clarithromycin—CYP3A4—Betamethasone—psoriasis	0.0033	0.0123	CbGbCtD
Clarithromycin—CYP3A4—Prednisolone—psoriasis	0.00325	0.0121	CbGbCtD
Clarithromycin—ABCB1—Dexamethasone—psoriasis	0.0032	0.0119	CbGbCtD
Clarithromycin—CYP3A4—Hydrocortisone—psoriasis	0.00308	0.0115	CbGbCtD
Clarithromycin—CYP3A4—Prednisone—psoriasis	0.00307	0.0114	CbGbCtD
Clarithromycin—CYP3A4—Cyclosporine—psoriasis	0.00291	0.0109	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—psoriasis	0.00257	0.00958	CbGbCtD
Clarithromycin—CYP3A4—Dexamethasone—psoriasis	0.00192	0.00715	CbGbCtD
Clarithromycin—CYP3A7—Xenobiotics—CYP2S1—psoriasis	8.15e-05	0.0784	CbGpPWpGaD
Clarithromycin—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	7.35e-05	0.0707	CbGpPWpGaD
Clarithromycin—CYP3A5—Xenobiotics—CYP2S1—psoriasis	5.89e-05	0.0567	CbGpPWpGaD
Clarithromycin—CYP2C19—Xenobiotics—CYP2S1—psoriasis	4.55e-05	0.0438	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL22—psoriasis	3.57e-05	0.0343	CbGpPWpGaD
Clarithromycin—CYP1A2—Xenobiotics—CYP2S1—psoriasis	3.55e-05	0.0342	CbGpPWpGaD
Clarithromycin—Convulsion—Betamethasone—psoriasis	3.5e-05	0.000373	CcSEcCtD
Clarithromycin—Convulsion—Dexamethasone—psoriasis	3.5e-05	0.000373	CcSEcCtD
Clarithromycin—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.49e-05	0.000372	CcSEcCtD
Clarithromycin—Insomnia—Hydrocortisone—psoriasis	3.49e-05	0.000372	CcSEcCtD
Clarithromycin—Paraesthesia—Hydrocortisone—psoriasis	3.47e-05	0.00037	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.47e-05	0.000369	CcSEcCtD
Clarithromycin—Urticaria—Cyclosporine—psoriasis	3.45e-05	0.000368	CcSEcCtD
Clarithromycin—Myalgia—Betamethasone—psoriasis	3.44e-05	0.000367	CcSEcCtD
Clarithromycin—Myalgia—Dexamethasone—psoriasis	3.44e-05	0.000367	CcSEcCtD
Clarithromycin—Body temperature increased—Cyclosporine—psoriasis	3.44e-05	0.000366	CcSEcCtD
Clarithromycin—Abdominal pain—Cyclosporine—psoriasis	3.44e-05	0.000366	CcSEcCtD
Clarithromycin—Anxiety—Betamethasone—psoriasis	3.43e-05	0.000365	CcSEcCtD
Clarithromycin—Anxiety—Dexamethasone—psoriasis	3.43e-05	0.000365	CcSEcCtD
Clarithromycin—Vomiting—Mycophenolic acid—psoriasis	3.42e-05	0.000364	CcSEcCtD
Clarithromycin—Discomfort—Dexamethasone—psoriasis	3.4e-05	0.000362	CcSEcCtD
Clarithromycin—Discomfort—Betamethasone—psoriasis	3.4e-05	0.000362	CcSEcCtD
Clarithromycin—Dyspepsia—Hydrocortisone—psoriasis	3.4e-05	0.000362	CcSEcCtD
Clarithromycin—Haemoglobin—Methotrexate—psoriasis	3.4e-05	0.000362	CcSEcCtD
Clarithromycin—Rash—Mycophenolic acid—psoriasis	3.39e-05	0.000361	CcSEcCtD
Clarithromycin—Dermatitis—Mycophenolic acid—psoriasis	3.38e-05	0.000361	CcSEcCtD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	3.38e-05	0.0326	CbGpPWpGaD
Clarithromycin—Pain—Prednisolone—psoriasis	3.38e-05	0.00036	CcSEcCtD
Clarithromycin—Haemorrhage—Methotrexate—psoriasis	3.38e-05	0.00036	CcSEcCtD
Clarithromycin—Hepatitis—Methotrexate—psoriasis	3.38e-05	0.00036	CcSEcCtD
Clarithromycin—Urticaria—Mycophenolate mofetil—psoriasis	3.37e-05	0.000359	CcSEcCtD
Clarithromycin—Headache—Mycophenolic acid—psoriasis	3.37e-05	0.000359	CcSEcCtD
Clarithromycin—Decreased appetite—Hydrocortisone—psoriasis	3.36e-05	0.000358	CcSEcCtD
Clarithromycin—Pharyngitis—Methotrexate—psoriasis	3.36e-05	0.000357	CcSEcCtD
Clarithromycin—Body temperature increased—Mycophenolate mofetil—psoriasis	3.35e-05	0.000357	CcSEcCtD
Clarithromycin—Abdominal pain—Mycophenolate mofetil—psoriasis	3.35e-05	0.000357	CcSEcCtD
Clarithromycin—Urinary tract disorder—Methotrexate—psoriasis	3.34e-05	0.000356	CcSEcCtD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	3.34e-05	0.0321	CbGpPWpGaD
Clarithromycin—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.34e-05	0.000355	CcSEcCtD
Clarithromycin—Fatigue—Hydrocortisone—psoriasis	3.33e-05	0.000355	CcSEcCtD
Clarithromycin—Urethral disorder—Methotrexate—psoriasis	3.31e-05	0.000353	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.31e-05	0.000353	CcSEcCtD
Clarithromycin—Pain—Hydrocortisone—psoriasis	3.3e-05	0.000352	CcSEcCtD
Clarithromycin—Anaphylactic shock—Dexamethasone—psoriasis	3.3e-05	0.000352	CcSEcCtD
Clarithromycin—Anaphylactic shock—Betamethasone—psoriasis	3.3e-05	0.000352	CcSEcCtD
Clarithromycin—Insomnia—Triamcinolone—psoriasis	3.29e-05	0.00035	CcSEcCtD
Clarithromycin—Infection—Dexamethasone—psoriasis	3.28e-05	0.000349	CcSEcCtD
Clarithromycin—Infection—Betamethasone—psoriasis	3.28e-05	0.000349	CcSEcCtD
Clarithromycin—Ill-defined disorder—Prednisone—psoriasis	3.27e-05	0.000348	CcSEcCtD
Clarithromycin—Paraesthesia—Triamcinolone—psoriasis	3.27e-05	0.000348	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisolone—psoriasis	3.26e-05	0.000347	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—psoriasis	3.26e-05	0.000347	CcSEcCtD
Clarithromycin—Anaemia—Prednisone—psoriasis	3.26e-05	0.000347	CcSEcCtD
Clarithromycin—Dyspnoea—Triamcinolone—psoriasis	3.24e-05	0.000345	CcSEcCtD
Clarithromycin—Nervous system disorder—Betamethasone—psoriasis	3.24e-05	0.000345	CcSEcCtD
Clarithromycin—Nervous system disorder—Dexamethasone—psoriasis	3.24e-05	0.000345	CcSEcCtD
Clarithromycin—Agitation—Prednisone—psoriasis	3.24e-05	0.000345	CcSEcCtD
Clarithromycin—Thrombocytopenia—Betamethasone—psoriasis	3.23e-05	0.000344	CcSEcCtD
Clarithromycin—Thrombocytopenia—Dexamethasone—psoriasis	3.23e-05	0.000344	CcSEcCtD
Clarithromycin—Angioedema—Prednisone—psoriasis	3.22e-05	0.000343	CcSEcCtD
Clarithromycin—Hypersensitivity—Cyclosporine—psoriasis	3.2e-05	0.000341	CcSEcCtD
Clarithromycin—Dyspepsia—Triamcinolone—psoriasis	3.2e-05	0.000341	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—psoriasis	3.2e-05	0.000341	CcSEcCtD
Clarithromycin—Nausea—Mycophenolic acid—psoriasis	3.19e-05	0.00034	CcSEcCtD
Clarithromycin—Hyperhidrosis—Betamethasone—psoriasis	3.19e-05	0.00034	CcSEcCtD
Clarithromycin—Hyperhidrosis—Dexamethasone—psoriasis	3.19e-05	0.00034	CcSEcCtD
Clarithromycin—Feeling abnormal—Hydrocortisone—psoriasis	3.18e-05	0.000339	CcSEcCtD
Clarithromycin—Malaise—Prednisone—psoriasis	3.18e-05	0.000338	CcSEcCtD
Clarithromycin—Vertigo—Prednisone—psoriasis	3.16e-05	0.000337	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—psoriasis	3.16e-05	0.000337	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Hydrocortisone—psoriasis	3.16e-05	0.000337	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—psoriasis	3.15e-05	0.000336	CcSEcCtD
Clarithromycin—Anorexia—Dexamethasone—psoriasis	3.15e-05	0.000335	CcSEcCtD
Clarithromycin—Anorexia—Betamethasone—psoriasis	3.15e-05	0.000335	CcSEcCtD
Clarithromycin—Urticaria—Prednisolone—psoriasis	3.14e-05	0.000335	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—psoriasis	3.14e-05	0.000334	CcSEcCtD
Clarithromycin—Fatigue—Triamcinolone—psoriasis	3.14e-05	0.000334	CcSEcCtD
Clarithromycin—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.12e-05	0.000333	CcSEcCtD
Clarithromycin—Asthenia—Cyclosporine—psoriasis	3.12e-05	0.000332	CcSEcCtD
Clarithromycin—Pain—Triamcinolone—psoriasis	3.11e-05	0.000331	CcSEcCtD
Clarithromycin—Loss of consciousness—Prednisone—psoriasis	3.1e-05	0.00033	CcSEcCtD
Clarithromycin—Pruritus—Cyclosporine—psoriasis	3.08e-05	0.000328	CcSEcCtD
Clarithromycin—Urticaria—Hydrocortisone—psoriasis	3.07e-05	0.000327	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—psoriasis	3.07e-05	0.000327	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—psoriasis	3.05e-05	0.000325	CcSEcCtD
Clarithromycin—Abdominal pain—Hydrocortisone—psoriasis	3.05e-05	0.000325	CcSEcCtD
Clarithromycin—Body temperature increased—Hydrocortisone—psoriasis	3.05e-05	0.000325	CcSEcCtD
Clarithromycin—Convulsion—Prednisone—psoriasis	3.05e-05	0.000325	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—psoriasis	3.05e-05	0.000325	CcSEcCtD
Clarithromycin—Asthenia—Mycophenolate mofetil—psoriasis	3.04e-05	0.000324	CcSEcCtD
Clarithromycin—Chills—Methotrexate—psoriasis	3.03e-05	0.000323	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.01e-05	0.00032	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Betamethasone—psoriasis	3.01e-05	0.00032	CcSEcCtD
Clarithromycin—Pruritus—Mycophenolate mofetil—psoriasis	3e-05	0.00032	CcSEcCtD
Clarithromycin—Myalgia—Prednisone—psoriasis	3e-05	0.000319	CcSEcCtD
Clarithromycin—Feeling abnormal—Triamcinolone—psoriasis	3e-05	0.000319	CcSEcCtD
Clarithromycin—Anxiety—Prednisone—psoriasis	2.99e-05	0.000318	CcSEcCtD
Clarithromycin—Insomnia—Betamethasone—psoriasis	2.99e-05	0.000318	CcSEcCtD
Clarithromycin—Insomnia—Dexamethasone—psoriasis	2.99e-05	0.000318	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.98e-05	0.000317	CcSEcCtD
Clarithromycin—Diarrhoea—Cyclosporine—psoriasis	2.97e-05	0.000317	CcSEcCtD
Clarithromycin—Paraesthesia—Dexamethasone—psoriasis	2.96e-05	0.000316	CcSEcCtD
Clarithromycin—Paraesthesia—Betamethasone—psoriasis	2.96e-05	0.000316	CcSEcCtD
Clarithromycin—Discomfort—Prednisone—psoriasis	2.96e-05	0.000316	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—psoriasis	2.96e-05	0.000316	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—psoriasis	2.94e-05	0.000314	CcSEcCtD
Clarithromycin—Hypersensitivity—Prednisolone—psoriasis	2.91e-05	0.00031	CcSEcCtD
Clarithromycin—Dyspepsia—Betamethasone—psoriasis	2.91e-05	0.000309	CcSEcCtD
Clarithromycin—Dyspepsia—Dexamethasone—psoriasis	2.91e-05	0.000309	CcSEcCtD
Clarithromycin—Diarrhoea—Mycophenolate mofetil—psoriasis	2.9e-05	0.000309	CcSEcCtD
Clarithromycin—Urticaria—Triamcinolone—psoriasis	2.89e-05	0.000308	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—psoriasis	2.88e-05	0.000307	CcSEcCtD
Clarithromycin—Body temperature increased—Triamcinolone—psoriasis	2.88e-05	0.000306	CcSEcCtD
Clarithromycin—Dizziness—Cyclosporine—psoriasis	2.87e-05	0.000306	CcSEcCtD
Clarithromycin—Anaphylactic shock—Prednisone—psoriasis	2.87e-05	0.000306	CcSEcCtD
Clarithromycin—Decreased appetite—Dexamethasone—psoriasis	2.87e-05	0.000306	CcSEcCtD
Clarithromycin—Decreased appetite—Betamethasone—psoriasis	2.87e-05	0.000306	CcSEcCtD
Clarithromycin—Infection—Prednisone—psoriasis	2.86e-05	0.000304	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Dexamethasone—psoriasis	2.85e-05	0.000304	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Betamethasone—psoriasis	2.85e-05	0.000304	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—psoriasis	2.85e-05	0.000303	CcSEcCtD
Clarithromycin—Hypersensitivity—Hydrocortisone—psoriasis	2.85e-05	0.000303	CcSEcCtD
Clarithromycin—Fatigue—Betamethasone—psoriasis	2.85e-05	0.000303	CcSEcCtD
Clarithromycin—Fatigue—Dexamethasone—psoriasis	2.85e-05	0.000303	CcSEcCtD
Clarithromycin—Pain—Dexamethasone—psoriasis	2.82e-05	0.000301	CcSEcCtD
Clarithromycin—Pain—Betamethasone—psoriasis	2.82e-05	0.000301	CcSEcCtD
Clarithromycin—Nervous system disorder—Prednisone—psoriasis	2.82e-05	0.0003	CcSEcCtD
Clarithromycin—Dizziness—Mycophenolate mofetil—psoriasis	2.8e-05	0.000299	CcSEcCtD
Clarithromycin—Skin disorder—Prednisone—psoriasis	2.79e-05	0.000297	CcSEcCtD
Clarithromycin—Hyperhidrosis—Prednisone—psoriasis	2.78e-05	0.000296	CcSEcCtD
Clarithromycin—Asthenia—Hydrocortisone—psoriasis	2.77e-05	0.000295	CcSEcCtD
Clarithromycin—Vomiting—Cyclosporine—psoriasis	2.76e-05	0.000294	CcSEcCtD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.74e-05	0.0264	CbGpPWpGaD
Clarithromycin—Rash—Cyclosporine—psoriasis	2.74e-05	0.000292	CcSEcCtD
Clarithromycin—Anorexia—Prednisone—psoriasis	2.74e-05	0.000292	CcSEcCtD
Clarithromycin—Dermatitis—Cyclosporine—psoriasis	2.74e-05	0.000292	CcSEcCtD
Clarithromycin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	2.74e-05	0.0264	CbGpPWpGaD
Clarithromycin—Pruritus—Hydrocortisone—psoriasis	2.73e-05	0.000291	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—psoriasis	2.73e-05	0.000291	CcSEcCtD
Clarithromycin—Headache—Cyclosporine—psoriasis	2.72e-05	0.00029	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—psoriasis	2.72e-05	0.00029	CcSEcCtD
Clarithromycin—Feeling abnormal—Betamethasone—psoriasis	2.72e-05	0.00029	CcSEcCtD
Clarithromycin—Feeling abnormal—Dexamethasone—psoriasis	2.72e-05	0.00029	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Dexamethasone—psoriasis	2.7e-05	0.000287	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Betamethasone—psoriasis	2.7e-05	0.000287	CcSEcCtD
Clarithromycin—Vomiting—Mycophenolate mofetil—psoriasis	2.7e-05	0.000287	CcSEcCtD
Clarithromycin—Hypersensitivity—Triamcinolone—psoriasis	2.68e-05	0.000285	CcSEcCtD
Clarithromycin—Rash—Mycophenolate mofetil—psoriasis	2.67e-05	0.000285	CcSEcCtD
Clarithromycin—Dermatitis—Mycophenolate mofetil—psoriasis	2.67e-05	0.000285	CcSEcCtD
Clarithromycin—Headache—Mycophenolate mofetil—psoriasis	2.66e-05	0.000283	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—psoriasis	2.65e-05	0.000283	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—psoriasis	2.64e-05	0.000282	CcSEcCtD
Clarithromycin—Diarrhoea—Hydrocortisone—psoriasis	2.64e-05	0.000282	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—psoriasis	2.63e-05	0.000281	CcSEcCtD
Clarithromycin—Urticaria—Betamethasone—psoriasis	2.62e-05	0.000279	CcSEcCtD
Clarithromycin—Urticaria—Dexamethasone—psoriasis	2.62e-05	0.000279	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Prednisone—psoriasis	2.62e-05	0.000279	CcSEcCtD
Clarithromycin—Dizziness—Prednisolone—psoriasis	2.62e-05	0.000279	CcSEcCtD
Clarithromycin—Asthenia—Triamcinolone—psoriasis	2.61e-05	0.000278	CcSEcCtD
Clarithromycin—Abdominal pain—Dexamethasone—psoriasis	2.61e-05	0.000278	CcSEcCtD
Clarithromycin—Abdominal pain—Betamethasone—psoriasis	2.61e-05	0.000278	CcSEcCtD
Clarithromycin—Body temperature increased—Betamethasone—psoriasis	2.61e-05	0.000278	CcSEcCtD
Clarithromycin—Body temperature increased—Dexamethasone—psoriasis	2.61e-05	0.000278	CcSEcCtD
Clarithromycin—Insomnia—Prednisone—psoriasis	2.6e-05	0.000277	CcSEcCtD
Clarithromycin—Nausea—Cyclosporine—psoriasis	2.58e-05	0.000275	CcSEcCtD
Clarithromycin—Paraesthesia—Prednisone—psoriasis	2.58e-05	0.000275	CcSEcCtD
Clarithromycin—Pruritus—Triamcinolone—psoriasis	2.57e-05	0.000274	CcSEcCtD
Clarithromycin—Cough—Methotrexate—psoriasis	2.57e-05	0.000274	CcSEcCtD
Clarithromycin—Dizziness—Hydrocortisone—psoriasis	2.55e-05	0.000272	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—psoriasis	2.55e-05	0.000272	CcSEcCtD
Clarithromycin—Dyspepsia—Prednisone—psoriasis	2.53e-05	0.00027	CcSEcCtD
Clarithromycin—Nausea—Mycophenolate mofetil—psoriasis	2.52e-05	0.000268	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—psoriasis	2.51e-05	0.000267	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—psoriasis	2.51e-05	0.000267	CcSEcCtD
Clarithromycin—Decreased appetite—Prednisone—psoriasis	2.5e-05	0.000266	CcSEcCtD
Clarithromycin—Rash—Prednisolone—psoriasis	2.49e-05	0.000266	CcSEcCtD
Clarithromycin—Dermatitis—Prednisolone—psoriasis	2.49e-05	0.000265	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.49e-05	0.000265	CcSEcCtD
Clarithromycin—Fatigue—Prednisone—psoriasis	2.48e-05	0.000264	CcSEcCtD
Clarithromycin—Headache—Prednisolone—psoriasis	2.48e-05	0.000264	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—psoriasis	2.48e-05	0.000264	CcSEcCtD
Clarithromycin—Constipation—Prednisone—psoriasis	2.46e-05	0.000262	CcSEcCtD
Clarithromycin—Vomiting—Hydrocortisone—psoriasis	2.46e-05	0.000262	CcSEcCtD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.45e-05	0.0235	CbGpPWpGaD
Clarithromycin—Rash—Hydrocortisone—psoriasis	2.44e-05	0.000259	CcSEcCtD
Clarithromycin—Dermatitis—Hydrocortisone—psoriasis	2.43e-05	0.000259	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—psoriasis	2.42e-05	0.000258	CcSEcCtD
Clarithromycin—Headache—Hydrocortisone—psoriasis	2.42e-05	0.000258	CcSEcCtD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.41e-05	0.0232	CbGpPWpGaD
Clarithromycin—Dizziness—Triamcinolone—psoriasis	2.41e-05	0.000256	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—psoriasis	2.4e-05	0.000256	CcSEcCtD
Clarithromycin—Infection—Methotrexate—psoriasis	2.39e-05	0.000254	CcSEcCtD
Clarithromycin—Feeling abnormal—Prednisone—psoriasis	2.37e-05	0.000252	CcSEcCtD
Clarithromycin—Asthenia—Dexamethasone—psoriasis	2.37e-05	0.000252	CcSEcCtD
Clarithromycin—Asthenia—Betamethasone—psoriasis	2.37e-05	0.000252	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—psoriasis	2.36e-05	0.000251	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—psoriasis	2.35e-05	0.000251	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Prednisone—psoriasis	2.35e-05	0.00025	CcSEcCtD
Clarithromycin—Nausea—Prednisolone—psoriasis	2.35e-05	0.00025	CcSEcCtD
Clarithromycin—Pruritus—Dexamethasone—psoriasis	2.34e-05	0.000249	CcSEcCtD
Clarithromycin—Pruritus—Betamethasone—psoriasis	2.34e-05	0.000249	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—psoriasis	2.33e-05	0.000249	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—psoriasis	2.32e-05	0.000247	CcSEcCtD
Clarithromycin—Vomiting—Triamcinolone—psoriasis	2.31e-05	0.000246	CcSEcCtD
Clarithromycin—Nausea—Hydrocortisone—psoriasis	2.29e-05	0.000244	CcSEcCtD
Clarithromycin—Rash—Triamcinolone—psoriasis	2.29e-05	0.000244	CcSEcCtD
Clarithromycin—Dermatitis—Triamcinolone—psoriasis	2.29e-05	0.000244	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—psoriasis	2.29e-05	0.000244	CcSEcCtD
Clarithromycin—Urticaria—Prednisone—psoriasis	2.28e-05	0.000243	CcSEcCtD
Clarithromycin—Headache—Triamcinolone—psoriasis	2.28e-05	0.000243	CcSEcCtD
Clarithromycin—Body temperature increased—Prednisone—psoriasis	2.27e-05	0.000242	CcSEcCtD
Clarithromycin—Abdominal pain—Prednisone—psoriasis	2.27e-05	0.000242	CcSEcCtD
Clarithromycin—Diarrhoea—Betamethasone—psoriasis	2.26e-05	0.000241	CcSEcCtD
Clarithromycin—Diarrhoea—Dexamethasone—psoriasis	2.26e-05	0.000241	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—psoriasis	2.19e-05	0.000233	CcSEcCtD
Clarithromycin—Dizziness—Betamethasone—psoriasis	2.18e-05	0.000232	CcSEcCtD
Clarithromycin—Dizziness—Dexamethasone—psoriasis	2.18e-05	0.000232	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—psoriasis	2.17e-05	0.000231	CcSEcCtD
Clarithromycin—Nausea—Triamcinolone—psoriasis	2.16e-05	0.00023	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—psoriasis	2.16e-05	0.00023	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—psoriasis	2.14e-05	0.000228	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—psoriasis	2.14e-05	0.000227	CcSEcCtD
Clarithromycin—Hypersensitivity—Prednisone—psoriasis	2.12e-05	0.000226	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—psoriasis	2.11e-05	0.000225	CcSEcCtD
Clarithromycin—Vomiting—Dexamethasone—psoriasis	2.1e-05	0.000224	CcSEcCtD
Clarithromycin—Vomiting—Betamethasone—psoriasis	2.1e-05	0.000224	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—psoriasis	2.09e-05	0.000222	CcSEcCtD
Clarithromycin—Rash—Betamethasone—psoriasis	2.08e-05	0.000222	CcSEcCtD
Clarithromycin—Rash—Dexamethasone—psoriasis	2.08e-05	0.000222	CcSEcCtD
Clarithromycin—Dermatitis—Dexamethasone—psoriasis	2.08e-05	0.000221	CcSEcCtD
Clarithromycin—Dermatitis—Betamethasone—psoriasis	2.08e-05	0.000221	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—psoriasis	2.07e-05	0.000221	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—psoriasis	2.07e-05	0.000221	CcSEcCtD
Clarithromycin—Headache—Dexamethasone—psoriasis	2.07e-05	0.00022	CcSEcCtD
Clarithromycin—Headache—Betamethasone—psoriasis	2.07e-05	0.00022	CcSEcCtD
Clarithromycin—Asthenia—Prednisone—psoriasis	2.06e-05	0.00022	CcSEcCtD
Clarithromycin—Pain—Methotrexate—psoriasis	2.05e-05	0.000219	CcSEcCtD
Clarithromycin—Pruritus—Prednisone—psoriasis	2.03e-05	0.000217	CcSEcCtD
Clarithromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	2.01e-05	0.0194	CbGpPWpGaD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.98e-05	0.0191	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Methotrexate—psoriasis	1.98e-05	0.000211	CcSEcCtD
Clarithromycin—Diarrhoea—Prednisone—psoriasis	1.97e-05	0.000209	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—psoriasis	1.96e-05	0.000209	CcSEcCtD
Clarithromycin—Nausea—Betamethasone—psoriasis	1.96e-05	0.000209	CcSEcCtD
Clarithromycin—Nausea—Dexamethasone—psoriasis	1.96e-05	0.000209	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—psoriasis	1.91e-05	0.000203	CcSEcCtD
Clarithromycin—Dizziness—Prednisone—psoriasis	1.9e-05	0.000202	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—psoriasis	1.9e-05	0.000202	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—psoriasis	1.9e-05	0.000202	CcSEcCtD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.89e-05	0.0182	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.87e-05	0.018	CbGpPWpGaD
Clarithromycin—Vomiting—Prednisone—psoriasis	1.83e-05	0.000195	CcSEcCtD
Clarithromycin—Rash—Prednisone—psoriasis	1.81e-05	0.000193	CcSEcCtD
Clarithromycin—Dermatitis—Prednisone—psoriasis	1.81e-05	0.000193	CcSEcCtD
Clarithromycin—Headache—Prednisone—psoriasis	1.8e-05	0.000192	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—psoriasis	1.77e-05	0.000189	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—psoriasis	1.72e-05	0.000184	CcSEcCtD
Clarithromycin—Nausea—Prednisone—psoriasis	1.71e-05	0.000182	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—psoriasis	1.7e-05	0.000181	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—psoriasis	1.64e-05	0.000175	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—psoriasis	1.59e-05	0.000169	CcSEcCtD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.53e-05	0.0148	CbGpPWpGaD
Clarithromycin—Vomiting—Methotrexate—psoriasis	1.53e-05	0.000163	CcSEcCtD
Clarithromycin—Rash—Methotrexate—psoriasis	1.51e-05	0.000161	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—psoriasis	1.51e-05	0.000161	CcSEcCtD
Clarithromycin—Headache—Methotrexate—psoriasis	1.5e-05	0.00016	CcSEcCtD
Clarithromycin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	1.48e-05	0.0142	CbGpPWpGaD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.47e-05	0.0142	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP2S1—psoriasis	1.46e-05	0.014	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.45e-05	0.014	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	1.44e-05	0.0138	CbGpPWpGaD
Clarithromycin—Nausea—Methotrexate—psoriasis	1.43e-05	0.000152	CcSEcCtD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.19e-05	0.0115	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.14e-05	0.0109	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.12e-05	0.0108	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	1.05e-05	0.0101	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	1.04e-05	0.01	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.22e-06	0.00887	CbGpPWpGaD
Clarithromycin—SLC22A7—SLC-mediated transmembrane transport—CP—psoriasis	9.15e-06	0.00881	CbGpPWpGaD
Clarithromycin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.09e-06	0.00875	CbGpPWpGaD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—TP53—psoriasis	8.87e-06	0.00854	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	8.75e-06	0.00843	CbGpPWpGaD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.48e-06	0.00816	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	8.14e-06	0.00784	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	8.03e-06	0.00773	CbGpPWpGaD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	7.89e-06	0.0076	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	7.22e-06	0.00695	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	7.07e-06	0.00681	CbGpPWpGaD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.77e-06	0.00651	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-C—psoriasis	6.76e-06	0.0065	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL13—psoriasis	6.71e-06	0.00646	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	6.34e-06	0.00611	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	6.26e-06	0.00602	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	6.25e-06	0.00601	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL17A—psoriasis	6.18e-06	0.00595	CbGpPWpGaD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	6.15e-06	0.00592	CbGpPWpGaD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.91e-06	0.00569	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL12B—psoriasis	5.75e-06	0.00553	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-E—psoriasis	5.61e-06	0.0054	CbGpPWpGaD
Clarithromycin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	5.47e-06	0.00527	CbGpPWpGaD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.22e-06	0.00503	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	4.9e-06	0.00471	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	4.83e-06	0.00465	CbGpPWpGaD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.72e-06	0.00454	CbGpPWpGaD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	4.69e-06	0.00452	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—CP—psoriasis	4.65e-06	0.00448	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.64e-06	0.00447	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—CARM1—psoriasis	4.44e-06	0.00427	CbGpPWpGaD
Clarithromycin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.22e-06	0.00407	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL10—psoriasis	4.2e-06	0.00404	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL4—psoriasis	4.09e-06	0.00393	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-B—psoriasis	4e-06	0.00385	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	3.99e-06	0.00384	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.72e-06	0.00358	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.7e-06	0.00356	CbGpPWpGaD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.66e-06	0.00352	CbGpPWpGaD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.64e-06	0.00351	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.38e-06	0.00326	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.04e-06	0.00293	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NDUFA5—psoriasis	2.93e-06	0.00282	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.63e-06	0.00253	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.53e-06	0.00243	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP2S1—psoriasis	2.49e-06	0.0024	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IFNG—psoriasis	2.47e-06	0.00238	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.47e-06	0.00237	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.3e-06	0.00221	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.3e-06	0.00221	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.15e-06	0.00207	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NDUFA5—psoriasis	2.12e-06	0.00204	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.97e-06	0.00189	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.97e-06	0.00189	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.89e-06	0.00182	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.87e-06	0.0018	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP2S1—psoriasis	1.8e-06	0.00173	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NDUFA5—psoriasis	1.64e-06	0.00158	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—TNF—psoriasis	1.6e-06	0.00154	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NDUFA5—psoriasis	1.6e-06	0.00154	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.59e-06	0.00153	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.53e-06	0.00147	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.49e-06	0.00143	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.42e-06	0.00136	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP2S1—psoriasis	1.39e-06	0.00134	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP2S1—psoriasis	1.36e-06	0.00131	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NDUFA5—psoriasis	1.28e-06	0.00123	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CARM1—psoriasis	1.22e-06	0.00117	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.19e-06	0.00115	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP2S1—psoriasis	1.08e-06	0.00104	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.05e-06	0.00101	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.01e-06	0.000976	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NDUFA5—psoriasis	9.85e-07	0.000948	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.21e-07	0.000886	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CARM1—psoriasis	8.8e-07	0.000847	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP2S1—psoriasis	8.37e-07	0.000806	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.89e-07	0.00076	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CAT—psoriasis	7.48e-07	0.00072	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.3e-07	0.000702	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.96e-07	0.00067	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CARM1—psoriasis	6.8e-07	0.000655	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CARM1—psoriasis	6.64e-07	0.000639	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.36e-07	0.000612	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—APOE—psoriasis	5.81e-07	0.00056	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.69e-07	0.000547	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CAT—psoriasis	5.41e-07	0.000521	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CARM1—psoriasis	5.3e-07	0.00051	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PPARG—psoriasis	5.06e-07	0.000488	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.95e-07	0.000477	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—APOE—psoriasis	4.2e-07	0.000405	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CAT—psoriasis	4.18e-07	0.000403	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CARM1—psoriasis	4.09e-07	0.000394	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CAT—psoriasis	4.08e-07	0.000393	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PPARG—psoriasis	3.66e-07	0.000352	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CAT—psoriasis	3.26e-07	0.000314	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—APOE—psoriasis	3.25e-07	0.000313	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—APOE—psoriasis	3.17e-07	0.000305	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PPARG—psoriasis	2.83e-07	0.000273	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PPARG—psoriasis	2.76e-07	0.000266	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—APOE—psoriasis	2.53e-07	0.000244	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CAT—psoriasis	2.52e-07	0.000242	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PPARG—psoriasis	2.21e-07	0.000212	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—APOE—psoriasis	1.95e-07	0.000188	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PPARG—psoriasis	1.7e-07	0.000164	CbGpPWpGaD
